Quarterly report [Sections 13 or 15(d)]

Unaudited Condensed Consolidated Balance Sheets

v3.25.2
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jul. 31, 2025
Jan. 31, 2025
Current assets:    
Cash and cash equivalents $ 100,512 $ 100,766
Restricted cash 2,908 2,571
Accounts receivable, net of allowance for credit losses of approximately $321 and $501 as of July 31, 2025 and January 31, 2025, respectively 96,778 178,989
Prepaid expenses and other current assets 52,581 50,527
Total current assets 252,779 332,853
Goodwill 317,071 317,071
Intangible assets, net 374,654 427,221
Other assets 24,922 28,924
Total assets 969,426 1,106,069
Current liabilities:    
Current maturities of long-term debt 6,404 6,404
Borrowings under accounts receivable facility 1,000 1,000
Accounts payable 26,794 13,458
Accrued compensation 26,096 47,803
Accrued expenses and other current liabilities 21,265 26,022
Deferred revenue 215,309 282,295
Total current liabilities 296,868 376,982
Long-term debt 571,203 573,267
Deferred tax liabilities 39,360 42,039
Deferred revenue - non-current 1,000 1,656
Other long-term liabilities 18,542 18,279
Total long-term liabilities 630,105 635,241
Commitments and contingencies
Shareholders’ equity (deficit):    
Shareholders’ common stock - Class A common shares, $0.0001 par value: 18,750,000 shares authorized and 8,972,560 shares issued and 8,672,783 shares outstanding as of July 31, 2025, and 8,616,633 shares issued and 8,316,856 shares outstanding as of January 31, 2025 1 1
Additional paid-in capital 1,572,538 1,565,040
Accumulated (deficit) (1,505,223) (1,443,386)
Treasury stock, at cost - 299,777 shares as of July 31, 2025 and January 31, 2025 (10,891) (10,891)
Accumulated other comprehensive income (loss) (13,972) (16,918)
Total shareholders’ equity (deficit) 42,453 93,846
Total liabilities and shareholders’ equity (deficit) $ 969,426 $ 1,106,069